Effects of serotonin reuptake inhibitors on hemostasis

Annals of Pharmacotherapy

Volumn 30, Issue 11, 1996, Pages 1232-1234

  Alderman, Christopher P ^a,b   Seshadri, Prabha ^a   Ben Tovim, David I ^c  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; BILIRUBIN; COLLAGEN; CREATININE; FLUOXETINE; PAROXETINE; RISTOCETIN; SEROTONIN UPTAKE INHIBITOR; UREA;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING TIME; BLOOD CHEMISTRY; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DRUG SAFETY; ELECTROLYTE BLOOD LEVEL; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE AGGREGATION; UREA BLOOD LEVEL;

EID: 0029956740     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603001103     Document Type: Article

References (17)

1. Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ. Fluoxetine and bleeding in obsessive compulsive disorder (letter). Am J Psychiatry 1991;148:949.
2. Aranth J, Lindberg C. Bleeding, a side effect of fluoxetine (letter). Am J Psychiatry 1992;149:412.
3. Gunzberger DW, Martinez D. Adverse vascular effects associated with fluoxetine (letter). Am J Psychiatry 1992;149:1751.
4. Ottervanger JP, van den Bemt PM, de Koning GH, Stricker BH. Risk of haemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Feverin) (abstract). Nederlands Tijdschrift voor Geneeskunde 1993;137:259.
5. Ottervanger JP, Stricker BH, Huls J, Weeda JN. Bleeding attributed to the intake of paroxetine. Am J Psychiatry 1994;151:781-2.
6. Humphries JE, Wheby MS, VandenBerg SR. Fluoxetine and the bleeding time. Arch Pathol Lab Med 1990;114:727-8.
7. Evans TG, Buys SS, Rodgers GM. Acquired abnormalities of platelet function (letter). N Engl J Med 1991;324:1671.
8. Alderman CP, Moritz CK, Ben-Tovim DI. Abnormal platelet aggregation associated with fluoxetine therapy. Ann Pharmacother 1992;26: 1517-9.
9. Calhoun JW, Calhoun DD. Prolonged bleeding time in a patient treated with sertraline (letter). Am J Psychiatry 1996;153:443.
10. Stanford MS, Patton JH. In utero exposure to fluoxetine HCl increases hematoma frequency at birth. Pharmacol Biochem Behav 1993;45:959-62.
11. Bannister SJ, Hauser VP, Hulse JD. Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin and digoxin. Acta Psychiatr Scand 1989;80(suppl 350):102-6.
12. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16:1-20.
13. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991;77:2547-52.
14. Bergstrom RF, Lemberger L, Farid NA, Wolen RL. Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Psychol 1989; 153(suppl 3):47-50.
15. Wernicke JF. The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985;46(3, sec 2):59-67.
16. Bang NU. Acquired abnormalities of platelet function (letter). N Engl J Med 1991;324:1672.
17. Berk M, Jacobson BF, Hurly E. Fluoxetine and hemostatic function: a pilot study. J Clin Psychiatry 1995;56:14-6.